Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Montelukast | hsa00190 | Oxidative phosphorylation | 1.18E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Montelukast | hsa00220 | Arginine biosynthesis | 2.86E-02 | 2 | P15104, P05089 | GLUL, ARG1 | More | | Montelukast | hsa00250 | Alanine, aspartate and glutamate metabolism | 8.48E-03 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | | Montelukast | hsa00270 | Cysteine and methionine metabolism | 2.39E-02 | 2 | Q96RQ9, P40926 | IL4I1, MDH2 | More | | Montelukast | hsa00280 | Valine, leucine and isoleucine degradation | 8.48E-03 | 2 | Q96RQ9, P05166 | IL4I1, PCCB | More | | Montelukast | hsa00310 | Lysine degradation | 4.50E-02 | 2 | Q9NVH6, O15047 | TMLHE, SETD1A | More | | Montelukast | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Montelukast | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Montelukast | hsa00591 | Linoleic acid metabolism | 1.29E-03 | 1 | P11712 | CYP2C9 | More | | Montelukast | hsa00600 | Sphingolipid metabolism | 4.50E-02 | 1 | P15289 | ARSA | More | | Montelukast | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.65E-03 | 3 | P40926, P05166, P15104 | MDH2, PCCB, GLUL | More | | Montelukast | hsa00670 | One carbon pool by folate | 3.15E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Montelukast | hsa00860 | Porphyrin and chlorophyll metabolism | 3.15E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Montelukast | hsa00920 | Sulfur metabolism | 3.18E-02 | 1 | Q16762 | TST | More | | Montelukast | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Montelukast | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Montelukast | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Montelukast | hsa01100 | Metabolic pathways | 1.59E-02 | 17 | Q9UJ14, P15104, Q96DU7, Q08828, Q02153, P40926, Q86XP1, Q96RQ9, Q9UHK6, Q9H4F1, Q9BRR6, P05166, P12074, P05496, O15239, O15047, Q9NVH6 | GGTL3, GLUL, ITPKC, ADCY1, GUCY1B3, MDH2, DGKH, IL4I1, AMACR, ST6GALNAC4, ADPGK, PCCB, COX6A1, ATP5G1, NDUFA1, SETD1A, TMLHE | More | | Montelukast | hsa03008 | Ribosome biogenesis in eukaryotes | 4.42E-02 | 3 | Q9NYH9, P78345, Q9BVP2 | UTP6, RPP38, GNL3 | More | | Montelukast | hsa03013 | RNA transport | 6.53E-09 | 21 | O14980, P52298, Q09161, O14893, P61326, Q15287, Q9UBU9, Q9H307, Q7Z3B4, P35658, P63279, Q14152, P55884, O15371, O75822, P78345, P20042, Q14240, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, RNPS1, NXF1, PNN, NUP54, NUP214, UBE2I, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, EIF2S2, EIF4A2, TACC3, FMR1, FXR1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q9UBU7 | DBF4 | Protein DBF4 homolog A | O14980 | XPO1 | Exportin-1 | 0.943 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.888 | P51684 | CCR6 | C-C chemokine receptor type 6 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.924 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.742 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.742 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.853 | P51684 | CCR6 | C-C chemokine receptor type 6 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.771 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | P61326 | MAGOH | Protein mago nashi homolog | 0.737 | P51684 | CCR6 | C-C chemokine receptor type 6 | P61326 | MAGOH | Protein mago nashi homolog | 0.704 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.756 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.723 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q9H307 | PNN | Pinin | 0.722 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.787 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.774 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.811 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.725 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.781 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.751 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.736 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.902 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.734 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.701 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.731 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O15371 | EIF3D | Eukaryotic translation initiation factor 3 subunit D | 0.77 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.83 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.837 | P51684 | CCR6 | C-C chemokine receptor type 6 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.711 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.852 | P51684 | CCR6 | C-C chemokine receptor type 6 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.861 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.733 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.867 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.812 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.732 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.772 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.854 |
| Montelukast | hsa03020 | RNA polymerase | 4.40E-02 | 2 | P24928, P62487 | POLR2A, POLR2G | More | | Montelukast | hsa03040 | Spliceosome | 1.81E-06 | 16 | O43143, O60508, P08579, Q15427, P26368, P38159, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, SF3B4, U2AF2, RBMX, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Montelukast | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Montelukast | hsa03060 | Protein export | 1.43E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Montelukast | hsa04012 | ErbB signaling pathway | 3.74E-02 | 3 | P21860, Q13557, O14944 | ERBB3, CAMK2D, EREG | More | | Montelukast | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Montelukast | hsa04015 | Rap1 signaling pathway | 2.69E-03 | 11 | P20827, P49767, Q96FS4, P11215, P25116, Q8TEU7, Q13009, Q7LDG7, P42338, P08514, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, F2R, RAPGEF6, TIAM1, RASGRP2, PIK3CB, ITGA2B, PLCG1 | More | | Montelukast | hsa04020 | Calcium signaling pathway | 6.50E-04 | 6 | Q96DU7, P45880, Q13557, P21860, P51828, P23634 | ITPKC, VDAC2, CAMK2D, ERBB3, ADCY7, ATP2B4 | More | | Montelukast | hsa04022 | cGMP-PKG signaling pathway | 3.25E-03 | 8 | Q99941, P18848, P23634, Q8WYR1, P51828, P05141, P45880, P0DP24 | CREBL1, ATF4, ATP2B4, PIK3R5, ADCY7, SLC25A5, VDAC2, CALM2 | More | | Montelukast | hsa04060 | Cytokine-cytokine receptor interaction | 1.71E-02 | 9 | P27930, P14778, P26842, Q13651, P25024, P09341, P18510, P09603, P01730 | IL1R2, IL1R1, CD27, IL10RA, CXCR1, CXCL1, IL1RN, CSF1, CD4 | More | | Montelukast | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Montelukast | hsa04064 | NF-kappa B signaling pathway | 4.92E-02 | 6 | P10415, P51617, Q13546, Q9UDY8, Q13077, P24522 | BCL2, IRAK1, RIPK1, MALT1, TRAF1, GADD45A | More | | Montelukast | hsa04070 | Phosphatidylinositol signaling system | 4.07E-02 | 4 | P0DP23, Q14643, O14732, P17252 | CALM1, ITPR1, IMPA2, PRKCA | More | | Montelukast | hsa04071 | Sphingolipid signaling pathway | 1.13E-02 | 5 | P17252, Q16537, Q9BX95, P04637, P10415 | PRKCA, PPP2R5E, SGPP1, TP53, BCL2 | More | | Montelukast | hsa04120 | Ubiquitin mediated proteolysis | 1.68E-02 | 2 | O00762, Q14139 | UBE2C, UBE4A | More | | Montelukast | hsa04122 | Sulfur relay system | 3.18E-02 | 1 | Q16762 | TST | More | | Montelukast | hsa04141 | Protein processing in endoplasmic reticulum | 3.64E-02 | 5 | Q99941, O75460, P11142, Q9H3Z4, P07900 | CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1 | More | | Montelukast | hsa04145 | Phagosome | 6.28E-06 | 9 | Q15080, P14598, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Montelukast | hsa04151 | PI3K-Akt signaling pathway | 1.67E-03 | 18 | P62753, P42338, P43657, O43521, P27348, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P18848, O00141, Q6ZUJ8, P30281 | RPS6, PIK3CB, P2RY5, BCL2L11, YWHAQ, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, ATF4, SGK, PIK3AP1, CCND3 | More | | Montelukast | hsa04210 | Apoptosis | 3.63E-02 | 3 | O75460, O43521, P18848 | ERN1, BCL2L11, ATF4 | More | | Montelukast | hsa04217 | Necroptosis | 5.66E-03 | 5 | P15104, P05141, P01584, P0C0S5, Q9H444 | GLUL, SLC25A5, IL1B, H2AFZ, CHMP4B | More | | Montelukast | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.32E-03 | 9 | P51828, Q99941, Q16537, P0DP23, Q13557, P17252, P10415, P20020, P23634 | ADCY7, CREBL1, PPP2R5E, CALM1, CAMK2D, PRKCA, BCL2, ATP2B1, ATP2B4 | More | | Montelukast | hsa04270 | Vascular smooth muscle contraction | 2.89E-02 | 2 | P35579, P35318 | MYH9, ADM | More | | Montelukast | hsa04330 | Notch signaling pathway | 5.96E-04 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | | Montelukast | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Montelukast | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Montelukast | hsa04512 | ECM-receptor interaction | 3.73E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Montelukast | hsa04514 | Cell adhesion molecules | 8.19E-03 | 3 | P16109, P56750, O00501 | SELP, CLDN17, CLDN5 | More | | Montelukast | hsa04530 | Tight junction | 2.47E-05 | 5 | Q8TEU7, P16989, P56750, O00501, Q14247 | RAPGEF6, CSDA, CLDN17, CLDN5, CTTN | More | | Montelukast | hsa04540 | Gap junction | 2.72E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Montelukast | hsa04610 | Complement and coagulation cascades | 4.47E-02 | 2 | P25116, P09871 | F2R, C1S | More | | Montelukast | hsa04611 | Platelet activation | 5.18E-05 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Montelukast | hsa04613 | Neutrophil extracellular trap formation | 1.41E-05 | 17 | P17252, P16109, P11215, O60603, P08246, Q92769, Q6FI13, Q93077, P62807, P33778, O60814, P68431, P14598, Q15080, P08514, P21462, P07359 | PRKCA, SELP, ITGAM, TLR2, ELA2, HDAC2, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC3, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, ITGA2B, FPR1, GP1BA | More | | Montelukast | hsa04623 | Cytosolic DNA-sensing pathway | 4.32E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Montelukast | hsa04640 | Hematopoietic cell lineage | 7.16E-03 | 7 | P13612, P14778, P27930, P07766, P01730, P09564, P09603 | ITGA4, IL1R1, IL1R2, CD3E, CD4, CD7, CSF1 | More | | Montelukast | hsa04658 | Th1 and Th2 cell differentiation | 4.54E-03 | 6 | P07766, P20963, P01730, P06239, Q9UL17, Q13761 | CD3E, CD247, CD4, LCK, TBX21, RUNX3 | More | | Montelukast | hsa04659 | Th17 cell differentiation | 7.46E-04 | 11 | P19174, P01730, P06239, P14784, P14778, Q9UL17, P84022, Q13485, P08238, P07766, P20963 | PLCG1, CD4, LCK, IL2RB, IL1R1, TBX21, SMAD3, SMAD4, HSP90AB1, CD3E, CD247 | More | | Montelukast | hsa04662 | B cell receptor signaling pathway | 1.74E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Montelukast | hsa04664 | Fc epsilon RI signaling pathway | 1.48E-03 | 6 | P42338, Q9UQC2, P07948, P19174, P09917, P20292 | PIK3CB, GAB2, LYN, PLCG1, ALOX5, ALOX5AP | More | | Montelukast | hsa04666 | Fc gamma R-mediated phagocytosis | 3.21E-05 | 6 | P23528, P49006, P06396, O14494, P14598, P17252 | CFL1, MARCKSL1, GSN, PLPP1, NCF1, PRKCA | More | | Montelukast | hsa04668 | TNF signaling pathway | 3.36E-03 | 5 | Q99941, P18848, P01584, P20333, O95429 | CREBL1, ATF4, IL1B, TNFRSF1B, BAG4 | More | | Montelukast | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Montelukast | hsa04713 | Circadian entrainment | 9.20E-03 | 4 | Q13557, Q02153, P61952, Q08828 | CAMK2D, GUCY1B3, GNG11, ADCY1 | More | | Montelukast | hsa04720 | Long-term potentiation | 1.17E-03 | 4 | P17252, Q16566, P0DP23, Q14643 | PRKCA, CAMK4, CALM1, ITPR1 | More | | Montelukast | hsa04723 | Retrograde endocannabinoid signaling | 3.86E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Montelukast | hsa04724 | Glutamatergic synapse | 2.72E-03 | 5 | P48058, P43003, P63218, P50151, P15104 | GRIA4, SLC1A3, GNG5, GNG10, GLUL | More | | Montelukast | hsa04725 | Cholinergic synapse | 7.09E-03 | 5 | Q14643, P17252, P62873, Q16566, P10415 | ITPR1, PRKCA, GNB1, CAMK4, BCL2 | More | | Montelukast | hsa04727 | GABAergic synapse | 1.36E-03 | 6 | Q08828, P63218, P50151, P61952, P15104, Q15111 | ADCY1, GNG5, GNG10, GNG11, GLUL, PLCL1 | More | | Montelukast | hsa04744 | Phototransduction | 4.54E-04 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Montelukast | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.74E-02 | 3 | P01584, P51828, Q13557 | IL1B, ADCY7, CAMK2D | More | | Montelukast | hsa04810 | Regulation of actin cytoskeleton | 2.58E-02 | 3 | Q15746, P08514, P25116 | MYLK, ITGA2B, F2R | More | | Montelukast | hsa04911 | Insulin secretion | 1.04E-03 | 4 | Q08828, P51828, Q99941, Q13557 | ADCY1, ADCY7, CREBL1, CAMK2D | More | | Montelukast | hsa04912 | GnRH signaling pathway | 4.42E-02 | 3 | P17252, Q14643, P0DP23 | PRKCA, ITPR1, CALM1 | More | | Montelukast | hsa04915 | Estrogen signaling pathway | 4.72E-02 | 4 | Q99941, P51828, P07900, P11142 | CREBL1, ADCY7, HSP90AA1, HSPA8 | More | | Montelukast | hsa04916 | Melanogenesis | 2.21E-03 | 4 | P0DP23, Q9UJU2, P17252, P04628 | CALM1, LEF1, PRKCA, WNT1 | More | | Montelukast | hsa04925 | Aldosterone synthesis and secretion | 2.56E-05 | 9 | Q14643, Q99941, P51828, P0DP23, P17252, Q16566, Q13557, P20020, P23634 | ITPR1, CREBL1, ADCY7, CALM1, PRKCA, CAMK4, CAMK2D, ATP2B1, ATP2B4 | More | | Montelukast | hsa04932 | Non-alcoholic fatty liver disease | 2.05E-03 | 5 | O43521, P18848, O75460, P01584, P13073 | BCL2L11, ATF4, ERN1, IL1B, COX4I1 | More | | Montelukast | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Montelukast | hsa04934 | Cushing syndrome | 8.32E-05 | 5 | Q99941, Q08828, P51828, O15169, Q13557 | CREBL1, ADCY1, ADCY7, AXIN1, CAMK2D | More | | Montelukast | hsa04962 | Vasopressin-regulated water reabsorption | 7.22E-03 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | | Montelukast | hsa04966 | Collecting duct acid secretion | 2.20E-03 | 3 | Q13488, P02730, Q9Y666 | TCIRG1, SLC4A1, SLC12A7 | More | | Montelukast | hsa04970 | Salivary secretion | 1.00E-02 | 4 | Q14643, P20020, P17252, P0DP23 | ITPR1, ATP2B1, PRKCA, CALM1 | More | | Montelukast | hsa04971 | Gastric acid secretion | 1.48E-02 | 3 | P51828, P15311, Q13557 | ADCY7, VIL2, CAMK2D | More | | Montelukast | hsa04972 | Pancreatic secretion | 1.00E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | | Montelukast | hsa04976 | Bile secretion | 4.50E-02 | 1 | Q9BY07 | SLC4A5 | More | | Montelukast | hsa05010 | Alzheimer disease | 1.35E-04 | 15 | P49768, Q92542, O15239, P05496, P13073, P12074, O75460, P0DP24, P01584, Q12933, P18848, O15169, P05141, P45880, P43686 | PSEN1, NCSTN, NDUFA1, ATP5G1, COX4I1, COX6A1, ERN1, CALM2, IL1B, TRAF2, ATF4, AXIN1, SLC25A5, VDAC2, PSMC4 | More | | Montelukast | hsa05012 | Parkinson disease | 3.89E-02 | 5 | P13073, P05141, O75460, P18848, P0DP24 | COX4I1, SLC25A5, ERN1, ATF4, CALM2 | More | | Montelukast | hsa05016 | Huntington disease | 4.87E-02 | 5 | P13073, P24928, P62487, P05141, O75460 | COX4I1, POLR2A, POLR2G, SLC25A5, ERN1 | More | | Montelukast | hsa05020 | Prion disease | 4.54E-03 | 14 | P01584, P46531, P11142, Q16718, O14521, P05496, P12074, Q14643, P45880, Q13509, P68371, Q99941, P14598, Q15080 | IL1B, NOTCH1, HSPA8, NDUFA5, SDHD, ATP5G1, COX6A1, ITPR1, VDAC2, TUBB3, TUBB2C, CREBL1, NCF1, NCF4 | More | | Montelukast | hsa05022 | Pathways of neurodegeneration - multiple diseases | 8.21E-05 | 27 | Q14643, Q13509, P68371, P10415, O15239, Q16718, O14521, P13073, P12074, P05496, O75460, P18848, Q12933, Q13561, P05141, P17252, P20333, O15169, P04628, P01584, P49768, O15020, P0DP23, P0DP24, Q13557, P62987, P43686 | ITPR1, TUBB3, TUBB2C, BCL2, NDUFA1, NDUFA5, SDHD, COX4I1, COX6A1, ATP5G1, ERN1, ATF4, TRAF2, DCTN2, SLC25A5, PRKCA, TNFRSF1B, AXIN1, WNT1, IL1B, PSEN1, SPTBN2, CALM1, CALM2, CAMK2D, UBA52, PSMC4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.793 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.787 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.908 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.919 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | -0.834 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.709 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.719 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | -0.715 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | -0.815 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q12933 | TRAF2 | TNF receptor-associated factor 2 | -0.771 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q13561 | DCTN2 | Dynactin subunit 2 | -0.876 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P17252 | PRKCA | Protein kinase C alpha type | 0.887 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15169 | AXIN1 | Axin-1 | -0.74 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P04628 | WNT1 | Proto-oncogene Wnt-1 | 0.732 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P49768 | PSEN1 | Presenilin-1 | -0.732 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | O15020 | SPTBN2 | Spectrin beta chain, non-erythrocytic 2 | -0.718 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P0DP23 | CALM1 | Calmodulin-1 | -0.815 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | -0.85 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P62987 | UBA52 | Ubiquitin-60S ribosomal protein L40 | 0.772 | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | -0.729 |
| Montelukast | hsa05034 | Alcoholism | 3.11E-05 | 6 | Q96RR4, Q93077, P62807, O60814, P84243, P68431 | CAMKK2, HIST1H2AC, HIST1H2BC, H2BC12, H3F3A, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Montelukast | hsa05130 | Pathogenic Escherichia coli infection | 7.39E-03 | 4 | Q14247, P56750, O00501, P25116 | CTTN, CLDN17, CLDN5, F2R | More | | Montelukast | hsa05132 | Salmonella infection | 8.23E-06 | 12 | P51617, Q9UJU2, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, P51808, Q13561, Q13509, P68371 | IRAK1, LEF1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DYNLT3, DCTN2, TUBB3, TUBB2C | More | | Montelukast | hsa05133 | Pertussis | 2.41E-02 | 2 | P09871, Q02556 | C1S, IRF8 | More | | Montelukast | hsa05140 | Leishmaniasis | 1.56E-02 | 5 | P14598, O60603, P49006, P51617, Q15080 | NCF1, TLR2, MARCKSL1, IRAK1, NCF4 | More | | Montelukast | hsa05146 | Amoebiasis | 4.54E-03 | 6 | Q13751, P09341, P14778, P27930, P05089, P12814 | LAMB3, CXCL1, IL1R1, IL1R2, ARG1, ACTN1 | More | | Montelukast | hsa05152 | Tuberculosis | 6.49E-05 | 9 | Q13488, P0DP23, P48382, O60603, P10415, P13765, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, TLR2, BCL2, HLA-DOB, IFNA21, MALT1, IRAK1 | More | | Montelukast | hsa05169 | Epstein-Barr virus infection | 2.54E-02 | 8 | Q92769, P04637, Q13546, P10415, P24522, O60603, P51617, P09693 | HDAC2, TP53, RIPK1, BCL2, GADD45A, TLR2, IRAK1, CD3G | More | | Montelukast | hsa05170 | Human immunodeficiency virus 1 infection | 3.40E-06 | 14 | P62873, P0DP23, P17252, Q13546, O00463, Q14643, P01568, P51617, O60603, P23528, P09693, P10415, Q93034, Q9Y6Q5 | GNB1, CALM1, PRKCA, RIPK1, TRAF5, ITPR1, IFNA21, IRAK1, TLR2, CFL1, CD3G, BCL2, CUL5, AP1M2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P10415 | BCL2 | Apoptosis regulator Bcl-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.777 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.805 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P0DP23 | CALM1 | Calmodulin-1 | -0.772 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P0DP23 | CALM1 | Calmodulin-1 | -0.815 | P51684 | CCR6 | C-C chemokine receptor type 6 | P0DP23 | CALM1 | Calmodulin-1 | -0.734 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P17252 | PRKCA | Protein kinase C alpha type | 0.844 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P17252 | PRKCA | Protein kinase C alpha type | 0.887 | P51684 | CCR6 | C-C chemokine receptor type 6 | P17252 | PRKCA | Protein kinase C alpha type | 0.738 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.819 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.868 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.773 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.858 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.793 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.81 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P01568 | IFNA21 | Interferon alpha-21 | 0.721 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P01568 | IFNA21 | Interferon alpha-21 | 0.876 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | P51684 | CCR6 | C-C chemokine receptor type 6 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.722 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | O60603 | TLR2 | Toll-like receptor 2 | -0.788 | P51684 | CCR6 | C-C chemokine receptor type 6 | O60603 | TLR2 | Toll-like receptor 2 | -0.767 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P23528 | CFL1 | Cofilin-1 | 0.741 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P23528 | CFL1 | Cofilin-1 | 0.8 | P51684 | CCR6 | C-C chemokine receptor type 6 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.753 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.919 | P51684 | CCR6 | C-C chemokine receptor type 6 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.84 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q93034 | CUL5 | Cullin-5 | 0.704 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.901 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.838 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.86 |
| Montelukast | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Montelukast | hsa05202 | Transcriptional misregulation in cancer | 3.51E-02 | 11 | Q12778, Q15532, P14780, P14923, Q16548, Q13489, Q13077, P35226, P05164, P08246, Q9C0K0 | FOXO1, SS18, MMP9, JUP, BCL2A1, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL11B | More | | Montelukast | hsa05203 | Viral carcinogenesis | 2.93E-03 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Montelukast | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Montelukast | hsa05205 | Proteoglycans in cancer | 1.09E-02 | 10 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P04628, Q13635, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, WNT1, PTCH1, CD63 | More | | Montelukast | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Montelukast | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Montelukast | hsa05214 | Glioma | 1.00E-02 | 4 | P0DP23, P17252, P04637, P24522 | CALM1, PRKCA, TP53, GADD45A | More | | Montelukast | hsa05216 | Thyroid cancer | 1.85E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Montelukast | hsa05217 | Basal cell carcinoma | 4.42E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Montelukast | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Montelukast | hsa05320 | Autoimmune thyroid disease | 5.52E-04 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Montelukast | hsa05322 | Systemic lupus erythematosus | 1.44E-05 | 10 | P08246, P09871, P10747, P13765, Q6FI13, Q93077, P62807, O60814, P68431, P05455 | ELA2, C1S, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, SSB | More | | Montelukast | hsa05323 | Rheumatoid arthritis | 2.72E-02 | 4 | P13765, Q13488, P10747, O60603 | HLA-DOB, TCIRG1, CD28, TLR2 | More | | |